Dr. Susan Moore

Dr. Susan Moore

BA (Geography), University of British Columbia
BSc (Microbiology), University of Victoria
PhD (Biochemistry), University of Victoria

Team: 
Associate Members
Positions: 

Laboratory Manager, Vancouver Prostate Centre
Adjunct Professor, Department of Medicine, University of British Columbia
Chairman, Vancouver Coastal Health Research Institute Joint Health & Safety Committee

 

Dr. Moore joined the VPC in 2003 as a Post-doctoral Fellow, bringing her own funding via an NSERC Fellowship and a Michael Smith Foundation Trainee Award.  She was promoted to a Research Associate in 2008; has served on the VCHRI Joint Health and Safety Committee since 2004 and as Chair since 2007; and started teaching in 2007 in the UBC Department of Medicine Undergraduate MD program where she was appointed  Adjunct Faculty in 2009.

As Lab Manager, Dr. Moore is responsible for managing day-to-day operations of the Vancouver Prostate Centre research labs.  She monitors and analyzes lab performance to ensure maximum efficiency, and ensures adherence to required regulations and effective lab supply management practices are in place.  She is the key point of contact for all equipment related responsibilities and issues.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.